Literature DB >> 4759869

The evolution of an evaluation: methodological problems in programs for school age mothers.

L V Klerman, J F Jekel, J B Currie, I W Gabrielson, P M Sarrel.   

Abstract

Mesh:

Year:  1973        PMID: 4759869      PMCID: PMC1775351          DOI: 10.2105/ajph.63.12.1040

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  8 in total

1.  RELATIONSHIP OF SELECTED PRENATAL FACTORS TO PREGNANCY OUTCOME AND CONGENITAL ANOMALIES.

Authors:  S SHAPIRO; L J ROSS; H S LEVIN
Journal:  Am J Public Health Nations Health       Date:  1965-02

2.  Mass survey detected lung cancer in Connecticut, 1949-1953.

Authors:  R A GREENBERG
Journal:  Conn State Med J       Date:  1956-11

3.  Teen-age births: some social, psychological, and physical sequelae.

Authors:  W C Oppel; A B Royston
Journal:  Am J Public Health       Date:  1971-04       Impact factor: 9.308

4.  High-risk obstetrics. II. Value of semiobjective grading system in identifying the vulnerable group.

Authors:  R E Nesbitt; R H Aubry
Journal:  Am J Obstet Gynecol       Date:  1969-04-01       Impact factor: 8.661

5.  Strategy and tactics of evaluating a large-scale medical care program.

Authors:  H R Kelman; J Elinson
Journal:  Med Care       Date:  1969 Mar-Apr       Impact factor: 2.983

6.  The young unwed mother. Obstetric results of a program of comprehensive care.

Authors:  P M Sarrel; L V Klerman
Journal:  Am J Obstet Gynecol       Date:  1969-10-15       Impact factor: 8.661

7.  A new approach to educational services for the pregnant student.

Authors:  M E Holmes; L V Klerman; I W Gabrielson
Journal:  J Sch Health       Date:  1970-04       Impact factor: 2.118

8.  An analysis of statistical methods for comparing obstetric outcomes: infant health in three samples of school-age pregnancies.

Authors:  J F Jekel; J B Currie; L V Klerman; C P McCarthy; P M Sarrel; R A Greenberg
Journal:  Am J Obstet Gynecol       Date:  1972-01-01       Impact factor: 8.661

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.